The French Alliance for Life and Health Sciences

Pr André Syrota
3rd International Biomedical Research Meeting
June 10th 2011
Résidence de Marigny
The French Alliance for Life and
Health Sciences: Aviesan
Created in April 2009
To optimise scientific foresight and put forward scientific
programming to Funding Agencies
To facilitate the development of top-level clusters and
research centers
To promote national projects and to set up national core
facilities
• Research operating agencies :
• Inserm
• CNRS life sciences department
• CEA (atomic energy commission)
• Inra (national institute for agricultural research)
• Inria (computer science and automatic control)
• IRD (research for development)
• Pasteur Institute
• Universities
• Hospitals
2
Ten Thematic Institutes
covering the entire field of Life and health Sciences
Genetics,
Cell Biology
Genomics
Bioinformatics Development
Neurosciences
Cognitive Sciences
Neurology,
Psychiatry
Immunology
Microbiology
Hematology
Infectious
Respiratory
diseases
diseases
Keywords: Sharing a common strategy
to ensure an improved coordination
Molecular
and
Structural
Biology
Nutrition
Circulation
Cancer
Public
Health
Health
Technologies
Metabolism
3
« Epidemiologie France » : a new
internet portal for health research
•
A web catalog of major health databases from French sources that may be useful to improve
research and public health expertise
•
This catalog contains descriptions of 237 databases including 130 cohort studies, 76 industrial
studies and 31 morbidity registries
•
A standardized description form for each database describes the main features: aims, population,
methods, acces modes, responsible of the database
•
Search engine and browse tools allows the visitor to explore the on line catalog in three ways:
browse, simple and advanced search
•
English version under construction
http://epidemiologie-france.fr
Investments for the future : a major
opportunity for boosting R&I
35 billion €
21.9 devoted to
Research and
Higher
education
10 cohorts
•
•
•
•
•
•
•
•
•
•
CANTO (breast cancer) : Institut Gustave Roussy / Inserm
OFSEP (multiple sclerosis) : Université Claude Bernard Lyon 1 / Hospices
civils de Lyon / Inserm
RADICO (rare diseases) : Inserm
i-SHARE (relationship between behaviour or exposure and pathogenesis
among young adults) : Université de Bordeaux / Inserm / Université de
Versailles Saint Quentin
E4N (genetics and biological risk factors) : Institut Gustave Roussy / Inserm
HOPE-EPI (pediatric cancers) : Inserm
CKD-REIN (chronic renal insufficiency) : Université Paris Sud 11
CRYOSTEM (transplant rejection and leukemia) : Société Française de
Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
COBLAnce (bladder cancer) : Inserm
Psy-COH (chronic psychiatric disorders) : Fondation FondaMental
70 millions € for 10 years
9 national research infrastructures
for biology and health
•
•
•
•
•
•
•
•
•
BIOBANQUES (public health, biomarkers), coordination Inserm
F- CRIN (clinical research), coordination Inserm
HIDDEN (biosafety level 4 laboratory), Inserm
France-BioImaging (cell imaging), coordination CNRS
FRISBI (structural biology), coordination CNRS
PHENOMIN (phenotyping), coordination CNRS
ProFI (proteomics), coordination CNRS
France Génomique (genomics), coordination CEA
EMBRC-France (marine biology), université Pierre et Marie Curie, CNRS
220 millions € for 10 years
6 university hospitals
« Instituts hospitalo-universitaires »
•
•
•
•
•
•
Neurosciences (Paris)
Cardiometabolism and nutrition (Paris)
Genetic diseases (Paris)
Cardiology (Bordeaux)
Surgery (Strasbourg)
Infectious diseases (Marseille)
350 millions € for 10 years
www.aviesan.fr
10